Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
3.230
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Savara Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
37
Market Cap
676.56M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Orthofix Medical | 784.25M |
Bioventus | 555.06M |
Evolus | 248.33M |
Axogen | 180.86M |
IRADIMED CORPORATION | 71.31M |
CureVac | 70.57M |
Dianthus Therapeutics | 5.37M |
Keros Therapeutics | 651.00K |
SVRA News
- 3 days ago - Savara Initiates Rolling Submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Business Wire
- 4 days ago - Savara Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 weeks ago - Savara Announces New Employment Inducement Grant - Business Wire
- 4 weeks ago - Savara Announces Encore Presentation of Results from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the British Thoracic Society Winter Meeting 2024 - Business Wire
- 5 weeks ago - Savara Announces Participation in Upcoming Healthcare Conferences - Business Wire
- 5 weeks ago - Savara Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 6 weeks ago - Savara to Present at the Guggenheim Inaugural Healthcare Innovation Conference - Business Wire
- 2 months ago - Savara Announces the Rare Lung Disease, Autoimmune Pulmonary Alveolar Proteinosis (aPAP), is Highlighted on a New Episode of “The Balancing Act®” Airing on Lifetime® TV - Business Wire